Clinical usefulness of C-reactive protein-albumin-lymphocyte (CALLY) index as a prognostic biomarker in patients undergoing surgical resection of pancreatic cancer

Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics

Yoshinobu Kanda · Bone Marrow Transplantation · 2012 · 18.7K citations

Public Health, Biostatistics, Hematology +11

Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)

Katsuhiko Uesaka, Narikazu Boku, Akira Fukutomi et al. · The Lancet · 2016 · 1.1K citations

Medicine, Oncology, Chemotherapy +7

Relationship of Nutritional Status, Inflammation, and Serum Albumin Levels During Acute Illness: A Prospective Study

Andreas Eckart, Tristan Struja, Alexander Kutz et al. · The American Journal of Medicine · 2019 · 695 citations · Full text

Agriculture, Nutrition, Nutritional Sciences +14

Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05)

Fuyuhiko Motoi, Tomoo Kosuge, Hideki Ueno et al. · Japanese Journal of Clinical Oncology · 2018 · 534 citations · Full text

Medicine, Oncology, Surgery +15

CA19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Perioperative Therapy

Werner Hartwig, Oliver Strobel, Ulf Hinz et al. · Annals of Surgical Oncology · 2012 · 297 citations

Medicine, Oncology, Surgery +14